Related Experiment Video
Updated: Jun 19, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
The advancements and prospective developments in anti-tumor targeted therapy
Guorui Leng1, Baorong Duan2, Junjie Liu3
1School of Special Education and Rehabilitation, Binzhou Medical University, Yantai 264003, China.
This review explores anti-tumor materials for cancer diagnosis and treatment. It covers their mechanisms, advances, and clinical applications, offering insights into future personalized cancer therapies.
Area of Science:
- Oncology
- Biomaterials Science
- Nanotechnology
Background:
- Cancer remains a significant global health challenge.
- Anti-tumor materials offer novel approaches for cancer diagnosis and therapy.
- Research in this field faces challenges but holds immense promise.
Purpose of the Study:
- To comprehensively review the progress and clinical applications of anti-tumor materials.
- To classify anti-tumor materials and elucidate their mechanisms of action.
- To discuss future perspectives and challenges in anti-tumor materials research.
Main Methods:
- Literature review of anti-tumor materials research.
- Classification of materials based on targeting and therapeutic strategies.
- Analysis of research advances and clinical translation.
Main Results:
- Detailed overview of various anti-tumor materials.
- Discussion of mechanisms targeting tumor cells and utilizing therapeutic instruments.
- Summary of current research progress and clinical applications.
Conclusions:
- Anti-tumor materials are crucial for advancing cancer care.
- Future directions point towards more precise, efficient, and customized cancer treatments.
- Continued research is essential to overcome existing challenges and realize the full potential of these materials.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...